Halina Offner
Fondateur chez Artielle ImmunoTherapeutics, Inc.
Postes actifs de Halina Offner
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Artielle ImmunoTherapeutics, Inc.
 Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | Fondateur | 01/01/2004 | - |
| Corporate Officer/Principal | 01/01/2004 | - | |
| Oregon Health & Science University | Corporate Officer/Principal | - | - |
Historique de carrière de Halina Offner
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Founder | 1 |
Sectorielle
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Artielle ImmunoTherapeutics, Inc.
Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | Health Technology |
- Bourse
- Insiders
- Halina Offner
- Expérience
